Ares Financial Consulting’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$489K Buy
1,848
+49
+3% +$12.9K 0.34% 50
2026
Q2
$457K Buy
1,799
+79
+5% +$18.4K 0.33% 52
2026
Q1
$420K Buy
1,720
+361
+27% +$84.1K 0.33% 51
2025
Q4
$281K Buy
+1,359
New +$269K 0.27% 61

Other funds holding JNJ

Ares Financial Consulting's JNJ Position: Q3 2026 in Review

Ares Financial Consulting increased its Johnson & Johnson (JNJ) stake by 2.7% in Q3 2026, buying an estimated $12.9K and bringing the position to 1,848 shares worth $489K. The position accounts for 0.34% of the portfolio, ranked #50.

Ares Financial Consulting first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 3,394 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Ares Financial Consulting held 1,848 shares of Johnson & Johnson worth $489K as of Q3 2026.
  • Ares Financial Consulting bought 49 Johnson & Johnson shares in Q3 2026, an estimated $12.9K.
  • Johnson & Johnson made up 0.34% of Ares Financial Consulting's portfolio in Q3 2026, its #50 holding.
  • Ares Financial Consulting first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 3,394 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.